Literature DB >> 11240075

Treatment of severe pain from osteoarthritis with slow-release tramadol or dihydrocodeine in combination with NSAID's: a randomised study comparing analgesia, antinociception and gastrointestinal effects.

C H Wilder-Smith1, L Hill, K Spargo, A Kalla.   

Abstract

Opioids are increasingly used in the treatment of chronic non-malignant pain. The aim of this open-label, randomised, parallel group study was to compare analgesia and side-effects of two commonly used opioid analgesics, tramadol and dihydrocodeine, in long-acting formulations in 60 osteoarthritis patients with strong pain despite NSAID's. Dose titration based on effect was performed with the respective immediate release solutions given additionally to tramadol 100 mg bid and dihydrocodeine 60 mg bid during the first 4 days of the 1 month treatment. Electrical sensation and pain thresholds over the osteoarthritic joint and at a distant location and gastrointestinal transit times were performed before and during treatment. Thirty patients with pain controlled by NSAID's alone formed the comparator group. Pain intensities at rest and during movement decreased highly significantly with tramadol and dihydrocodeine from median pre-treatment verbal ratings of over 3 (0=none, 4=unbearable) to 1 and below from the second treatment day onwards (ANOVA P<0.0001). Pain at rest was significantly lower with tramadol (ANOVA P=0.04), but ratings were similar during movement. Mean (95% CI) daily doses on days 1 and 28 were 209 (198-220) mg and 203 (191-206) mg of tramadol, and 129 (122-136) mg and 130 (121-134) mg of dihydrocodeine, respectively. Minor side-effects were more common with tramadol (P=0.04). Changes in bowel functions and symptoms were minor with both treatments, but the frequency of defaecation was lower and stools were harder with dihydrocodeine. Orocaecal transit time remained unchanged and similar to controls with both analgesics. Colonic transit times only increased significantly during treatment with dihydrocodeine. Sensation and pain thresholds were lower pre-treatment in both groups than in controls and increased during treatment. These antinociceptive effects were more marked in the tramadol group and distant from the osteoarthritic joint. We conclude rapid pain relief was achieved with both long-acting tramadol and dihydrocodeine with NSAID's in strong osteoarthritis pain. Minimal dose titration was required and side-effects were minor. Tramadol interfered less with intestinal function and showed greater antinociceptive action.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11240075     DOI: 10.1016/s0304-3959(00)00414-0

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  23 in total

1.  Chronic pain and narcotics: a dilemma for primary care.

Authors:  Yngvild Olsen; Gail L Daumit
Journal:  J Gen Intern Med       Date:  2002-03       Impact factor: 5.128

2.  Tramadol for osteoarthritis.

Authors:  Karine Toupin April; Jacinthe Bisaillon; Vivian Welch; Lara J Maxwell; Peter Jüni; Anne Ws Rutjes; M Elaine Husni; Jennifer Vincent; Tania El Hindi; George A Wells; Peter Tugwell
Journal:  Cochrane Database Syst Rev       Date:  2019-05-27

3.  Effect of a simple dose-escalation schedule on tramadol tolerability : assessment in the clinical setting.

Authors:  I Tagarro; J Herrera; C Barutell; M C Díez; M Marín; D Samper; C Busquet; M J Rodríguez
Journal:  Clin Drug Investig       Date:  2005       Impact factor: 2.859

Review 4.  The pharmacotherapy of chronic pain: a review.

Authors:  Mary E Lynch; C Peter N Watson
Journal:  Pain Res Manag       Date:  2006       Impact factor: 3.037

Review 5.  Management of chronic arthritis pain in the elderly.

Authors:  Mary-Ann Fitzcharles; David Lussier; Yoram Shir
Journal:  Drugs Aging       Date:  2010-06-01       Impact factor: 3.923

6.  Treating stress-related pain with the flotation restricted environmental stimulation technique: are there differences between women and men?

Authors:  Sven A Bood; Anette Kjellgren; Torsten Norlander
Journal:  Pain Res Manag       Date:  2009 Jul-Aug       Impact factor: 3.037

Review 7.  Cervical myofascial pain and headache.

Authors:  Joanne Borg-Stein
Journal:  Curr Pain Headache Rep       Date:  2002-08

8.  A randomized, double-blind, crossover comparison of the efficacy and safety of oral controlled-release tramadol and placebo in patients with painful osteoarthritis.

Authors:  C Thorne; A D Beaulieu; D J Callaghan; W F O'Mahony; J M Bartlett; R Knight; G R Kraag; R Akhras; P S Piraino; J Eisenhoffer; Z Harsanyi; A C Darke
Journal:  Pain Res Manag       Date:  2008 Mar-Apr       Impact factor: 3.037

9.  Pharmacokinetic evaluation of a new oral sustained release dosage form of tramadol.

Authors:  H Malonne; B Sonet; B Streel; S Lebrun; S De Niet; A Sereno; F Vanderbist
Journal:  Br J Clin Pharmacol       Date:  2004-03       Impact factor: 4.335

Review 10.  Impact of opioid rescue medication for breakthrough pain on the efficacy and tolerability of long-acting opioids in patients with chronic non-malignant pain.

Authors:  J Devulder; A Jacobs; U Richarz; H Wiggett
Journal:  Br J Anaesth       Date:  2009-09-06       Impact factor: 9.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.